Diana Carmen Dragnea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Diana Carmen Dragnea has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Sorcha Ní Dhubhghaill
Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium
5 shared publications Gerrit R.J. Melles
Netherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands
2 shared publications- Jos J. Rozema
Antwerp University
2 shared publications - Marie-José Tassignon
Department of Ophthalmology, Antwerp University Hospital, Edegem, and Brussels University Hospital VUB, Belgium
2 shared publications - Silke Oellerich
Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium
2 shared publications Adrian Gericke
Department of Ophthalmology, University Medical Center Mainz, Germany
1 shared publication
Latest Publications
- Open Access
- 13 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (6) , 2214
Corneal Neurotization—Indications, Surgical Techniques and Outcomes
Corneal neurotization is a promising surgical approach for the treatment of moderate to severe neurotrophic keratopathy. This technique aims to restore corneal sensation by transferring healthy nerves, either directly or via a conduit, to the anesthetic cornea. This review provides a report on the current state of development, evidence, and experience in the field. We summarize the data available from clinical reports and case series, placing an emphasis on the diversity of the surgical techniques reported. While these data are encouraging, they also highlight the need for a consensus in reporting outcomes and highlight how the next step will involve validating putative outcome parameters when researching and reporting corneal neurotization surgery.
- 13 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (6) , 2214
Open AccessCorneal Neurotization—Indications, Surgical Techniques and Outcomes
Corneal neurotization is a promising surgical approach for the treatment of moderate to severe neurotrophic keratopathy. This technique aims to restore corneal sensation by transferring healthy nerves, either directly or via a conduit, to the anesthetic cornea. This review provides a report on the current state of development, evidence, and experience in the field. We summarize the data available from clinical reports and case series, placing an emphasis on the diversity of the surgical techniques reported. While these data are encouraging, they also highlight the need for a consensus in reporting outcomes and highlight how the next step will involve validating putative outcome parameters when researching and reporting corneal neurotization surgery.
- Open Access
- 27 August 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 28, 101693
Wave-like calcification on the posterior surface of an acrylic hydrophilic bag-in-the-lens (BIL) implant
- 27 August 2022
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 28, 101693
Open AccessWave-like calcification on the posterior surface of an acrylic hydrophilic bag-in-the-lens (BIL) implant
- 25 February 2022
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 240, 115-124
Influence of Author's Gender on the Peer-Review Process in Vision Science
- 25 February 2022
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 240, 115-124
Influence of Author's Gender on the Peer-Review Process in Vision Science
- 18 August 2021
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (5) , 568-575
Intraocular bag-in-the-lens exchange: indications, outcomes, and complications
Purpose: To report the indications, outcomes, and complications regarding bag-in-the-lens (BIL) intraocular lens (IOL) exchange over a period of 13 years in a tertiary ophthalmologic center. Setting: Department of Ophthalmology of the University Hospital of Antwerp, Belgium. Design: Observational retrospective study. Methods: Between 2003 and 2020, 12 176 patients were operated using the BIL technique. Adult patients who underwent an intraocular BIL exchange were included, and the demographics, indications, outcomes, and complications were recorded. Results: 59 eyes (0.48%) of 59 patients who underwent a BIL exchange between 2007 and 2020 were included. The mean age was 61.15 ± 13.53 years. The mean time between primary surgery and IOL exchange was 25.73 ± 41.88 months. The main indication for explantation was refractive surprise mostly related to patient risk factors, for example, preoperative corneal and refractive surgery. The mean preoperative uncorrected (UDVA) and corrected (CDVA) distance visual acuity were 0.36 ± 0.24 and 0.79 ± 0.24, respectively. The postoperative 1-month UDVA and CDVA were 0.66 ± 0.28 and 0.86 ± 0.19, respectively. The improvement in UDVA was statistically significant (<0.0001). The most common intraoperative complication was damage to the anterior hyaloid in 9 eyes (15%), which did not prohibit reimplantation of a secondary BIL. Conclusions: BIL to BIL exchange was a viable and successful technique that provides good refractive results with few, manageable complications. Because of the tertiary profile of the study center with referral of complex cases, BIL was the preferred IOL in patients at risk for postoperative refractive surprise.
- 18 August 2021
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 48 (5) , 568-575
Intraocular bag-in-the-lens exchange: indications, outcomes, and complications
Purpose: To report the indications, outcomes, and complications regarding bag-in-the-lens (BIL) intraocular lens (IOL) exchange over a period of 13 years in a tertiary ophthalmologic center. Setting: Department of Ophthalmology of the University Hospital of Antwerp, Belgium. Design: Observational retrospective study. Methods: Between 2003 and 2020, 12 176 patients were operated using the BIL technique. Adult patients who underwent an intraocular BIL exchange were included, and the demographics, indications, outcomes, and complications were recorded. Results: 59 eyes (0.48%) of 59 patients who underwent a BIL exchange between 2007 and 2020 were included. The mean age was 61.15 ± 13.53 years. The mean time between primary surgery and IOL exchange was 25.73 ± 41.88 months. The main indication for explantation was refractive surprise mostly related to patient risk factors, for example, preoperative corneal and refractive surgery. The mean preoperative uncorrected (UDVA) and corrected (CDVA) distance visual acuity were 0.36 ± 0.24 and 0.79 ± 0.24, respectively. The postoperative 1-month UDVA and CDVA were 0.66 ± 0.28 and 0.86 ± 0.19, respectively. The improvement in UDVA was statistically significant (<0.0001). The most common intraoperative complication was damage to the anterior hyaloid in 9 eyes (15%), which did not prohibit reimplantation of a secondary BIL. Conclusions: BIL to BIL exchange was a viable and successful technique that provides good refractive results with few, manageable complications. Because of the tertiary profile of the study center with referral of complex cases, BIL was the preferred IOL in patients at risk for postoperative refractive surprise.
- 13 August 2019
- Published by Wolters Kluwer Health in Cornea
- Vol. 39 (2) , 229-233
In Vitro Evaluation of the Feasibility of Slit-Lamp Nd:YAG Laser Descemetorhexis
Purpose: To evaluate in vitro the feasibility and tissue effects of using a slit-lamp neodymium-doped yttrium aluminum garnet (Nd:YAG) laser to create a central descemetorhexis in human donor corneas. Methods: Twelve human donor corneas ineligible for transplantation were divided into 2 groups, A and B. Group A: 2 “healthy” corneas, which were used to validate the laser parameters; group B: 10 corneas with endothelial guttae, which were used to perform a 4-mm descemetorhexis. Slit-lamp photography, light microscopy, corneal endothelial microscopy, Scheimpflug imaging, optical coherence tomography (OCT) imaging, and histological staining were performed to visualize the efficacy of slit-lamp Nd:YAG laser removal of Descemet membrane and to assess potential tissue damage to the overlying stroma and peripheral endothelium. Results: In all corneas, an Nd:YAG laser 4-mm central descemetorhexis could be consistently performed. The total energy required ranged from 1143 to 2784 mJ. Side effects such as stromal pitting and corneal swelling were observed. Conclusions: Creating a central descemetorhexis with a slit-lamp Nd:YAG laser proved feasible in vitro. This new technical approach might open the door to a customized in vivo “descemetorhexis-only” treatment for Fuchs endothelial corneal dystrophy eyes, while avoiding the risks associated with intraocular surgery.
- 13 August 2019
- Published by Wolters Kluwer Health in Cornea
- Vol. 39 (2) , 229-233
In Vitro Evaluation of the Feasibility of Slit-Lamp Nd:YAG Laser Descemetorhexis
Purpose: To evaluate in vitro the feasibility and tissue effects of using a slit-lamp neodymium-doped yttrium aluminum garnet (Nd:YAG) laser to create a central descemetorhexis in human donor corneas. Methods: Twelve human donor corneas ineligible for transplantation were divided into 2 groups, A and B. Group A: 2 “healthy” corneas, which were used to validate the laser parameters; group B: 10 corneas with endothelial guttae, which were used to perform a 4-mm descemetorhexis. Slit-lamp photography, light microscopy, corneal endothelial microscopy, Scheimpflug imaging, optical coherence tomography (OCT) imaging, and histological staining were performed to visualize the efficacy of slit-lamp Nd:YAG laser removal of Descemet membrane and to assess potential tissue damage to the overlying stroma and peripheral endothelium. Results: In all corneas, an Nd:YAG laser 4-mm central descemetorhexis could be consistently performed. The total energy required ranged from 1143 to 2784 mJ. Side effects such as stromal pitting and corneal swelling were observed. Conclusions: Creating a central descemetorhexis with a slit-lamp Nd:YAG laser proved feasible in vitro. This new technical approach might open the door to a customized in vivo “descemetorhexis-only” treatment for Fuchs endothelial corneal dystrophy eyes, while avoiding the risks associated with intraocular surgery.
- 19 October 2018
- Published by Wolters Kluwer Health in Cornea
- Vol. 38 (2) , 162-165
Postoperative Repositioning of Inverted Descemet Membrane Endothelial Keratoplasty Grafts
Purpose: To present 4 cases of postoperative repositioning of inverted grafts after Descemet membrane endothelial keratoplasty (DMEK). Methods: Retrospective case reports of 4 patients presenting with subtotal to total graft detachment after DMEK, most probably owing to upside-down graft positioning. Graft repositioning was performed 1 to 14 days after initial DMEK surgery. In 3 cases (cases 1, 3, and 4), repositioning was performed without removing the graft from the anterior chamber (AC), whereas for case 2, the graft had to be removed from the AC to attain correct graft orientation. Results: In all 4 cases, the initially upside-down DMEK grafts could be successfully repositioned postoperatively. Three cases showed complete graft attachment after graft repositioning with clear corneas until the last available follow-up. One case manifested a persistent central detachment with central corneal edema, eventually requiring re-DMEK. Endothelial cell density decreased from 2800 cells/mm2 preoperatively to 2373 cells/mm2 at 2 years postoperatively for case 1 and from 2600 to 600 cells/mm2 at 6 months postoperatively for case 2. Case 3 showed a clear cornea until the last available follow-up at 1 year postoperatively. Conclusions: In cases of upside-down grafts after DMEK, attempting to reposition the graft, with or without removing the graft from the AC, may be a cost- and tissue-efficient alternative before converting to re-DMEK.
- 19 October 2018
- Published by Wolters Kluwer Health in Cornea
- Vol. 38 (2) , 162-165
Postoperative Repositioning of Inverted Descemet Membrane Endothelial Keratoplasty Grafts
Purpose: To present 4 cases of postoperative repositioning of inverted grafts after Descemet membrane endothelial keratoplasty (DMEK). Methods: Retrospective case reports of 4 patients presenting with subtotal to total graft detachment after DMEK, most probably owing to upside-down graft positioning. Graft repositioning was performed 1 to 14 days after initial DMEK surgery. In 3 cases (cases 1, 3, and 4), repositioning was performed without removing the graft from the anterior chamber (AC), whereas for case 2, the graft had to be removed from the AC to attain correct graft orientation. Results: In all 4 cases, the initially upside-down DMEK grafts could be successfully repositioned postoperatively. Three cases showed complete graft attachment after graft repositioning with clear corneas until the last available follow-up. One case manifested a persistent central detachment with central corneal edema, eventually requiring re-DMEK. Endothelial cell density decreased from 2800 cells/mm2 preoperatively to 2373 cells/mm2 at 2 years postoperatively for case 1 and from 2600 to 600 cells/mm2 at 6 months postoperatively for case 2. Case 3 showed a clear cornea until the last available follow-up at 1 year postoperatively. Conclusions: In cases of upside-down grafts after DMEK, attempting to reposition the graft, with or without removing the graft from the AC, may be a cost- and tissue-efficient alternative before converting to re-DMEK.
- 16 August 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (5) , 1993-2003
Pattern noise (PANO): a new automated functional glaucoma test
To present a newly developed visual field device (pattern noise: PANO) designed to be sensitive to glaucoma defects, cost-effective, material-practical and easy to repair and therefore particularly suited for low-income countries, where glaucoma can be highly prevalent (e.g. sub-Saharan Africa).
- 16 August 2017
- Published by Springer Nature in International Ophthalmology
- Vol. 38 (5) , 1993-2003
Pattern noise (PANO): a new automated functional glaucoma test
To present a newly developed visual field device (pattern noise: PANO) designed to be sensitive to glaucoma defects, cost-effective, material-practical and easy to repair and therefore particularly suited for low-income countries, where glaucoma can be highly prevalent (e.g. sub-Saharan Africa).